FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and may be used to treat recurrent haemophthalmia in diabetic retinopathy. That is ensured by permanent administration of Endotelon 150 mg, Tranexam 500 mg, Dicynone 250 mg 2 times a day. They are added by Angiovit 1 tablet a day for 1 month, 3 times a year.
EFFECT: method enables providing the long-term remission and stabilisation of a visual function ensured by the complex effect on the morphofunctional changes of the endothelium and vascular-thrombocyte haemostatic disorders.
1 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF WIDE - SPREAD HEMOPHTHALMIA AND TOTAL HEMOPHTHALMIA TREATMENT IN PATIENTS WITH DIABETIC RETINOPATHY | 2008 |
|
RU2391954C2 |
PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
METHOD FOR APPLYING ENZYMOTHERAPY | 2006 |
|
RU2303457C1 |
METHOD OF HEMOPHTHALMIA TREATMENT | 2007 |
|
RU2352301C1 |
NON-SURGICAL METHOD FOR TREATING THE CASES OF HEMOPHTHALMIA | 2001 |
|
RU2196550C2 |
METHOD FOR DIABETIC RETINOPATHY WITH EXUDATIVE-HEMORRHAGIC MACULOPATHY ACCOMPANIED BY HYPOCOAGULATION AND HEMORRHAGIC SYNDROME | 2003 |
|
RU2245140C1 |
METHOD FOR PREVENTION OF INTRAOPERATIVE HAEMORRHAGIC COMPLICATIONS IN SURGERY OF PROLIFERATIVE DIABETIC RETINOPATHY | 2018 |
|
RU2703707C2 |
PREPARATION "GISTOKHROM" FOR TREATMENT OF EYE RETINA AND CORNEA INFLAMMATORY SICKNESSES | 1998 |
|
RU2134107C1 |
METHOD OF ASSAY OF MICROCIRCULATORY TYPE HEMORRHAGIC DIATHESIS IN LATENT PERIOD | 1996 |
|
RU2117297C1 |
METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
Authors
Dates
2013-06-27—Published
2012-04-25—Filed